SEARCH

SEARCH BY CITATION

References

  • 1
    McCance RA 1947 Osteomalacia with Looser's nodes (milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years Q J Med 16:3346.
  • 2
    Drezner MK, 1996 Tumor-associated rickets and osteomalacia. In: FavusMJ, (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd Ed. Lippincott-Raven, Philadelphia, PA, U.S.A., pp. 319325.
  • 3
    Lyles KW, 1996 Oncogenic osteomalacia. In: BilezikianJP, RaiszLG, RodanGA, (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, U.S.A., pp. 935940.
  • 4
    Siris ES, Clemens TL, Dempster DW, Shane E, Segre GV, Lindsay R, Bilezikian JP 1987 Tumor-induced osteomalacia: Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry Am J Med 82:307312.
  • 5
    Shane E, 1996 Hypercalcemia: Pathogenesis, clinical manifestations, and differential diagnosis. In: FavusMJ, (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd Ed. Lippincott-Raven, Philadelphia, PA, U.S.A., pp. 177181.
  • 6
    Delmas PD, Malaval L, Arlot M, Meunier PJ 1985 Serum bone gla-protein compared to bone histomorphometry in endocrine disease Bone 6:329341.
  • 7
    Gundberg CM, Wilson PS, Gallop PM, Parfitt AM 1985 Determination of osteocalcin in human serum: Results with two kits compared with those by a well-characterized assay Clin Chem 31:17201723.
  • 8
    Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT Jr, Segre GV 1987 Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia Clin Chem 33:13641367.
  • 9
    Preece MA, O'Riordan JLH, Lawson DEM, Kodicek E 1974 An assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum Clin Chim Acta 54:235242.
  • 10
    Reinhardt TA, Horst RL, Orf JW, Hollis BW 1984 A microassay for 1,25-dihydroxyvitamin D not requiring high-performance liquid chromotography: Application to clinical studies J Clin Endocrinol Metab 58:9198.
  • 11
    Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP, Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF 1990 Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer N Engl J Med 322:11061112.
  • 12
    Bijvoet OLM, 1980 Indices for the measurement of the renal handling of phosphate. In: MassrySG, FleischH, (eds.) Renal Handling of Phosphate. Plenum Press, New York, NY, U.S.A., pp. 137.
  • 13
    Kivirikko KI, Laitenen O, Prockop DJ 1967 Modification of a specific assay for hydroxyproline in urine Anal Biochem 19:249255.
  • 14
    Eyre DR, Koob TJ, Vanness KP 1984 Quantitation of hydroxypyridinium cross-links in collagen by high performance liquid chromotography Anal Biochem 137:380388.
  • 15
    Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N 1994 Perspective: The diagnosis of osteoporosis J Bone Miner Res 9:11371141.
  • 16
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2:595610.
  • 17
    Melsen F, Melsen B, Mosekilde L, Bergmann S 1978 Histomorphometric analysis of normal bone from the iliac crest Acta Pathol Microbiol Scand (A) 86:7077.
  • 18
    Clarke B, Ebeling P, Jones J, Wahner H, O'Fallon W, Riggs B, Fitzpatrick L 1996 Changes in quantitative bone histomorphometry in aging healthy men J Clin Endocrinol Metab 81:22642270.
  • 19
    Roberts AB, Lamb LC, Newton DL, Sporn MB, DeLarco JE, Todaro GJ 1980 Transforming growth factors: Isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction Proc Natl Acad Sci USA 77:34943498.
  • 20
    Cole JA, Forte LR, Krause WJ, Thorne PK 1989 Clonal sublines that are morphologically and functionally distinct from parental OK cells Am J Physiol 256:F672F679.
  • 21
    Malmstrom K, Murer H 1986 Parathyroid hormone inhibits phosphate transport in OK cells but not in LLC-PK1 and JTC-12P3 cells Am J Physiol 253:C23C31.
  • 22
    Henderson JE, He B, Goltzman D, Karaplis AC 1996 Constitutive expression of parathyroid hormone related peptide (PTHrP) stimulates growth and inhibits differentiation of CFK2 chondrocytes J Cell Physiol 169:3341.
  • 23
    Adams JS, Beeker TG, Hongo T, Clemens TL 1990 Constitutive expression of a vitamin D 1-hydroxylase in a myelomonocytic cell line: A model for studying 1,25-dihydroxyvitamin D production in vitro J Bone Miner Res 5:12651269.
  • 24
    Seibel MJ, Robins SP, Bilezikian JP 1992 Urinary pyridinium crosslinks of collagen: Specific markers of bone resorption in metabolic bone disease Trends Endocrinol Metab 3:263270.
  • 25
    Weidner N, Cruz DS 1985 Phosphaturic mesenchymal tumors: A polymorphous group causing osteomalacia or rickets Cancer 55:16911705.
  • 26
    Cheng CL, Su PC, Mason RS et al. 1989 Osteomalacia secondary to osteosarcoma J Bone Joint Surg 71:288292.
  • 27
    Schenker Y, Grenkin RJ 1984 Oncogenic osteomalacia Isr J Med Sci 20:739741.
  • 28
    Miller MJ, Marel G, Frame B, 1982 Adult acquired vitamin D and PTH-resistant hypophatemic osteomalacia with multiple skeletal lesions. In: NormanAW, SchaeferK, HerrathDV, GrigoleitHG, (eds.) Vitamin D—Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism. Walter de Gruyter, New York, NY, U.S.A., pp. 993995.
  • 29
    Leicht E, Biro G, Langer H-J 1990 Tumor-induced osteomalacia: Pre- and post-operative biochemical findings Horm Metab Res 22:640643.
  • 30
    Reid IR, Teitelbaum SL, Dusso A, Whyte MP 1987 Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia: Effect of successful tumor resection on mineral homeostasis Am J Med 83:350354.
  • 31
    Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R 1994 Brief report: Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia N Engl J Med 330:16451649.
  • 32
    Lotz M, Zinsman E, Bartter FC 1968 Evidence for a phosphate-depletion syndrome in man N Engl J Med 278:409415.
  • 33
    Raisz LG, Niemann I 1969 Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture Endocrinology 85:446452.
  • 34
    Qui MC, Mathews C, Parfitt AM, 1983 Osteoclastic resorption of osteoid in secondary hyperparathyroidism. In: FrameB, PottsJT, (eds.) Clinical Disorder of Bone and Mineral Metabolism. Excerpta Medica, Princeton, NJ, U.S.A., pp. 209212.
  • 35
    Schapira D, Ben Izhak, Nachtigal A, Burstein A, Bar Shalom, Shagrawi I, Best LA 1995 Tumor-induced osteomalacia Sem Arthr Rheum 25:3546.
  • 36
    Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB 1990 Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvariae J Cell Physiol 143:213221.
  • 37
    Bronckers ALJJ, Gay S, Finkelman RD, Butler WT 1987 Developmental appearance of the Gla proteins (osteocalcin) and alkaline phosphatase in tooth germs and bone of the rat J Bone Miner Res 2:361373.
  • 38
    Malaval L, Modrowski D, Gupta AK, Aubin JE 1994 Cellular expression of bone related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures J Cell Physiol 158:555572.
  • 39
    Kiriyama T, Fujiyama K, Ito M, Ejima E, Yokoyama N, Nagataki S 1995 Cultured oncogenic osteomalacia produce a factor(s) that inhibits osteocalcin production by osteoblastic cells J Bone Miner Res 10:155.
  • 40
    Aschinberg LC, Soloman LM, Zeis PM, Justice P, Rosenthal IM 1977 Vitamin D-resistant rickets associated with epidermal nevus syndrome: Demonstration of a phosphaturic substance in the dermal lesions J Pediatr 91:5660.
  • 41
    Miyauchi A, Fukase M, Tsutsumi M, Fujita T 1988 Hemangiopericytoma-induced osteomalacia: Tumor transplantation in nude mice causes hypophosphaturia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity J Clin Endocrinol Metab 67:4653.
  • 42
    Nitzan DW, Horowitz AT, Darmon D, Fredlander MM, Rubinger D, Stein P, Bab I, Popovzter MM, Silver J 1989 Oncogenous osteomalacia: A case study Bone Miner 6:191197.
  • 43
    Wilkins GE, Granleese S, Hegele RG, Holden J, Anderson DW, Bondy GP 1995 Oncogenic osteomalacia: Evidence for a humoral phosphaturic factor J Clin Endocrinol Metab 80:16281634.
  • 44
    Lajeuness D, Meyer RA, Hamel L 1996 Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse Kidney Int 50:15311538.
  • 45
    Tenenhouse HS, Martel J 1993 Renal adaptation to phosphate deprivation: Lessons from the X-linked mouse Pediatr Nephrol 7:312318.
  • 46
    Drezner MK, Feinglos MN 1977 Osteomalacia due to 1,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone J Clin Invest 60:10461053.
  • 47
    Lobaugh B, Burch WM Jr, Drezner MK, 1984 Abnormalities of vitamin D metabolism and action in the vitamin D resistant and rachitic and osteomalacic diseases. In: “Vitamin DRKumar, (ed.) Martinus Nijhoff, Boston, MA, U.S.A., pp. 665720.
  • 48
    Drezner MK, 1996 Phosphorus homeostasis and related disorders. In: BilezikianJP, RaiszLG, RodanGA, (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, U.S.A., pp. 263276.
  • 49
    Tenenhouse HS 1997 Review: Cellular and molecular mechanisms of renal phosphate transport J Bone Miner Res 12:159164.
  • 50
    Rasmussen H, Tenenhouse HS, 1995 Mendelian hypophosphatemias. In: ScriverCR, BeaudetAL, SlyWS, ValleD, (eds.) The Metabolic and Molecular Basis of Inherited Disease, 7th Ed. McGraw Hill Book Co., New York, NY, U.S.A., pp. 37173745.
  • 51
    The HYP Consortium 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphtemic rickets Nature Genet 11:130136.
  • 52
    Nesbitt T, Coffman TM, Griffiths R, Drezner MK 1992 Cross-transplantation of kidneys in normal and hyp-mice: Evidence that the hyp-mouse phenotype is unrelated to an intrinsic renal defect J Clin Invest 89:14531459.
  • 53
    Meyer RA Jr, Tenenhouse HS, Meyer MH, Klugerman AH 1989 The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy J Bone Miner Res 4:523532.
  • 54
    Meyer RA Jr, Meyer MH, Gray RW 1989 Parabiosis suggests that a humoral factor is involved in X-linked hypophosphatemia in mice J Bone Miner Res 4:493500.
  • 55
    Panda D, Lipman ML, Henderson JE, Shane E, Shen Y, Goltzman D, Karaplis AC 1997 Cloning of human PEX cDNA from tumors causing hypophosphatemic osteomalacia J Bone Miner Res 12:S43.